Veradermics, Incorporated · NYSE:MANE
Durso Timothy August sold 43,500 Veradermics, Incorporated shares (Form 4)
Traded Aug 17, 2026 · Filed Aug 18, 2026
On Aug 17, 2026, Durso Timothy August (Chief Technical Officer) sold 43,500 Veradermics, Incorporated shares at an average US$107.82 for US$4.69M under a trading plan, leaving 78,142 shares. Filed Aug 18, 2026 (Form 4).
- Sold
- 43,500 shares
- Price
- US$107.82 average (US$106.71 to US$111.28)
- Value
- US$4.69M
- Holding after
- 78,142 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Technical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Common Stock | Option exercise | 3,452 | US$12.19 | 121,642 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 7,918 | US$106.71 | 113,724 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 16,306 | US$107.52 | 97,418 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 16,767 | US$108.38 | 80,651 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 2,348 | US$109.34 | 78,303 | Direct |
| Aug 17, 2026 | Common Stock | Sale | 161 | US$111.28 | 78,142 | Direct |
Source
Related
- Veradermics, Incorporated
- Durso Timothy August
- Veradermics, Incorporated shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Hollander David · Sep 3, 2026
- Form 4 · Averill Master Fund, Ltd. · Aug 21, 2026
- Schedule 13D/A · Montanova Capital, LLC · Aug 21, 2026
- Form 4 · Waldman Reid Alexander · Aug 18, 2026